GB1523241A - 2-(carboxymethoxy)-chalcones - Google Patents

2-(carboxymethoxy)-chalcones

Info

Publication number
GB1523241A
GB1523241A GB3220/77A GB322077A GB1523241A GB 1523241 A GB1523241 A GB 1523241A GB 3220/77 A GB3220/77 A GB 3220/77A GB 322077 A GB322077 A GB 322077A GB 1523241 A GB1523241 A GB 1523241A
Authority
GB
United Kingdom
Prior art keywords
chalcones
carboxymethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3220/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of GB1523241A publication Critical patent/GB1523241A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB3220/77A 1976-02-13 1977-01-26 2-(carboxymethoxy)-chalcones Expired GB1523241A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1457876A JPS5297950A (en) 1976-02-13 1976-02-13 Chalconeether derivatives

Publications (1)

Publication Number Publication Date
GB1523241A true GB1523241A (en) 1978-08-31

Family

ID=11865033

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3220/77A Expired GB1523241A (en) 1976-02-13 1977-01-26 2-(carboxymethoxy)-chalcones

Country Status (12)

Country Link
US (1) US4085135A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5297950A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR209544A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1084064A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH605537A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2705603C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES455620A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2340924A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1523241A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU173019B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT66118B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU39378B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190671A (en) * 1977-03-17 1980-02-26 Biorex Laboratories Limited Chalcone derivatives
JPS5552597U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1978-09-30 1980-04-08
JPS62207212A (ja) * 1986-03-08 1987-09-11 Nippon Haipotsukusu:Kk 抗アレルギ−剤
US5089654A (en) * 1989-08-08 1992-02-18 Taisho Pharmaceutical Co., Ltd. Chalcone derivatives
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20010021625A (ko) 1997-07-09 2001-03-15 추후보정 개선된 남성발기 기능장애 치료방법 및 그 조성물
IL153565A0 (en) * 2000-06-20 2003-07-06 Atherogenics Inc 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
BR0115474A (pt) 2000-11-17 2006-01-31 Idenix Cayman Ltd Composição e método para inibição da transmissão de hiv que usam 6-benzil-4-oxopirimidinas substituìdas aplicada por via tópica
CA2470931A1 (en) * 2001-12-19 2003-07-03 Atherogenics, Inc. Chalcone derivatives and their use to treat diseases
US20040181075A1 (en) * 2002-12-19 2004-09-16 Weingarten M. David Process of making chalcone derivatives
US7173129B2 (en) * 2003-06-06 2007-02-06 Athero Genics, Inc. Sulfonamide-substituted chalcone derivatives and their use to treat diseases
WO2006004903A2 (en) * 2004-06-28 2006-01-12 Atherogenics, Inc. 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
GB2471619B (en) * 2008-03-31 2012-10-31 Council Scient Ind Res Method for the simultaneous preparation of 3-acetoxy-17-acetamdo-16-formyl-androst-5,16-diene and 3-acetoxy-2'-chloro-5-androsteno[17,6-B]pyridine
CN101792385B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅷ及其制备方法和用途
CN101781194B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅴ及其制备方法和用途
CN101817742B (zh) * 2009-12-10 2013-10-16 天津药物研究院 索法酮的晶型ⅹ及其制备方法和用途
CN101817741B (zh) * 2009-12-10 2013-10-16 天津药物研究院 索法酮的晶型ⅸ及其制备方法和用途
CN101735039B (zh) * 2009-12-10 2013-06-26 天津药物研究院 索法酮的晶型ⅱ及其制备方法和用途
CN101735038B (zh) * 2009-12-10 2013-06-26 天津药物研究院 索法酮的晶型ⅰ及其制备方法和用途
CN101781195B (zh) * 2009-12-10 2013-03-13 天津药物研究院 索法酮的晶型ⅶ及其制备方法和用途
CN101781193B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅳ及其制备方法和用途
CN101735040B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅲ及其制备方法和用途
CN101781192B (zh) * 2009-12-10 2013-05-15 天津药物研究院 索法酮的晶型ⅵ及其制备方法和用途
CN115368265B (zh) * 2022-10-24 2023-03-28 中国中医科学院中药研究所 一种索法酮小分子活性探针及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255241A (en) * 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
CH593224A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-10-30 1977-11-30 Taisho Pharmaceutical Co Ltd

Also Published As

Publication number Publication date
JPS5645896B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-10-29
PT66118B (en) 1978-06-28
HU173019B (hu) 1979-01-28
DE2705603C2 (de) 1986-07-24
CH605537A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-09-29
AR209544A1 (es) 1977-04-29
PT66118A (en) 1977-02-01
CA1084064A (en) 1980-08-19
YU8977A (en) 1982-06-30
FR2340924A1 (fr) 1977-09-09
JPS5297950A (en) 1977-08-17
YU39378B (en) 1984-12-31
US4085135A (en) 1978-04-18
FR2340924B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-03-23
DE2705603A1 (de) 1977-08-18
ES455620A1 (es) 1978-01-01
AU2131077A (en) 1978-01-26

Similar Documents

Publication Publication Date Title
AU517514B2 (en) 3-de-0-methylfortimicins
AU2542577A (en) 4-amino-4-arylcyclohexanones
AU2384277A (en) Triazolo-pyrimidines
GB1542539A (en) Bicycle-trailer
GB1523241A (en) 2-(carboxymethoxy)-chalcones
CS164777A2 (en) Zpusob ziskavani krystalickeho xylitolu farmaceuricke jakosti
GB1522457A (en) Benzocycloheptafurans
CS474677A2 (en) Obrazovy zesilovac
AU3191677A (en) Cyclopentan-1-amine
AU507260B2 (en) N-2-imidazolidinylidene-benzeneamine
AU2451277A (en) Isothiazolopyridines
AU2168677A (en) 2-(3-m-hydroxy-phenyl-1-substituted-3-pyrrolidinyl)- ethanol
AU1309176A (en) Fire-barriers
GB1538366A (en) Pyridobenzodiazepines
BG23251A1 (en) Stabilograph
GB1543517A (en) O-propyl-oximes
AU2893177A (en) Perhydroindolinols
GB1520699A (en) Benzoxazolenes
AU508067B2 (en) Electroradiography
AU2378777A (en) Amino - alkoxyalkanes
GB1537670A (en) De-tinning
GB1546029A (en) N-hydrocarbyloxymethyl-alpha-haloacetanilides
AU2493077A (en) 2-amino-substituted-isothioureido bewzenes
IE45688L (en) 2-(dimethylcarbamoylimino)-benzthiazolin-3-carboxylic acid¹esters
AU2710877A (en) Benzodioxepins

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930126